Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma - Grandclément, C; Estoppey, C; Dheilly, E; Panagopoulou, M; Monney, T; Dreyfus, C; Loyau, J; Labanca, V; Drake, A; De Angelis, S; Rubod, A; Frei, J; et al. (Nature Communications, 2024)